Eamonn Hobbs

Biography

  Eamonn Hobbs is President and CEO of Digital Cognition Technologies (DCT), a digital health company with patented technology proven to deliver accurate and objective early indicators of cognitive function. He is also Founder and President of Hobbs Medical Ventures, LLC, a healthcare consulting company. In 2016, Hobbs was appointed as Visiting Scholar, Lecturer and Entrepreneur in Residence at the Translational Accelerator of Brigham and Women’s Hospital, the teaching hospital of Harvard Medical School.Hobbs has had tremendous success in creating and growing companies in to long lasting, financially strong performers. His greatest achievement was AngioDynamics, Inc., which he founded as a division of a public parent company, E-Z-EM, Inc. (NASDAQ: EZEM) and lead through a value-creating carve out tax-free spin-off and simultaneous IPO (NASDAQ: ANGO).Hobbs was elected twice to be Chairman of the Medical Device Manufactures Association (MDMA). He has served on many public and private company Boards, including Antares Pharma, (NASDAQ: ATRS), where he later became interim President and CEO.He holds a B.S. degree in plastics engineering from University of Massachusetts, Lowell.

Research Interest

 Accounting and marketing